Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 6Warts 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Human Papillomavirus-Related Cervical Carcinoma 1Human Papillomavirus-Related Carcinoma 1Hematologic Neoplasms 1HIV Infections 1Condylomata Acuminata 1Acquired Immunodeficiency Syndrome 1

Interventions

plerixafor 1lactic acid, salicylic acid drug combination 1human papillomavirus vaccine, L1 type 16, 18 1Vitamin D 1VP-102 1Solutions 1Sodium Chloride 1Saline Solution 1Salicylic Acid 1Percutaneous Collagen Induction 1Ivermectin 1Hydrogen Peroxide 1Human Papillomavirus Recombinant Vaccine nonavalent 1Cantharidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Warts × Human Papillomavirus Recombinant Vaccine nonavalent × 1 year × Clear all
NCT05087849 2025-10-02

Intralesional HPV Vaccine for Condylomata

University of California, San Francisco

Phase 1/2 Completed
2 enrolled 7 charts

Condylomata Acuminata, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡